Clinical Trial Update: Convergent Mechanisms Underlying Reprometabolic Syndrome in Women [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating convergent mechanisms underlying reprometabolic syndrome in women, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility
• Obesity

Snippet

Sponsor: University of Colorado, Denver | Conditions: Infertility, Female, Obesity | Phase 2 | Status: RECRUITING